世界の有毛細胞白血病治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hairy Cell Leukemia Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2657 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、有毛細胞白血病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（デザペリシブ、ELB-021、イブルチニブ、AGS-67E、ARABS-4、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・有毛細胞白血病治療の市場動向 ・企業の競争状況、市場シェア ・有毛細胞白血病治療の種類別市場規模（デザペリシブ、ELB-021、イブルチニブ、AGS-67E、ARABS-4、その他） ・有毛細胞白血病治療の用途別市場規模（病院、クリニック、その他） ・有毛細胞白血病治療の北米市場規模2016-2027（アメリカ、カナダ） ・有毛細胞白血病治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・有毛細胞白血病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・有毛細胞白血病治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・有毛細胞白血病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie Inc、ARA Healthcare Pvt Ltd、Astellas Pharma Inc.、Cellectis SA、F. Hoffmann-La Roche Ltd、Incyte Corp、Juno Therapeutics Inc、MedImmune LLC、Novartis AG） ・結論

Market Analysis and Insights: Global Hairy Cell Leukemia Therapeutics Market
The global Hairy Cell Leukemia Therapeutics market size is projected to reach US$ 119.1 million by 2026, from US$ 86 million in 2019, at a CAGR of 4.8% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hairy Cell Leukemia Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hairy Cell Leukemia Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hairy Cell Leukemia Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hairy Cell Leukemia Therapeutics market.

Global Hairy Cell Leukemia Therapeutics Scope and Market Size
Hairy Cell Leukemia Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hairy Cell Leukemia Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Dezapelisib
ELB-021
Ibrutinib
AGS-67E
ARABS-4
Others

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie Inc
ARA Healthcare Pvt Ltd
Astellas Pharma Inc.
Cellectis SA
F. Hoffmann-La Roche Ltd
Incyte Corp
Juno Therapeutics Inc
MedImmune LLC
Novartis AG

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hairy Cell Leukemia Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Dezapelisib
1.2.3 ELB-021
1.2.4 Ibrutinib
1.2.5 AGS-67E
1.2.6 ARABS-4
1.2.7 Others
1.3 Market by Application
1.3.1 Global Hairy Cell Leukemia Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hairy Cell Leukemia Therapeutics Market Perspective (2016-2027)
2.2 Hairy Cell Leukemia Therapeutics Growth Trends by Regions
2.2.1 Hairy Cell Leukemia Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hairy Cell Leukemia Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Hairy Cell Leukemia Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Hairy Cell Leukemia Therapeutics Industry Dynamic
2.3.1 Hairy Cell Leukemia Therapeutics Market Trends
2.3.2 Hairy Cell Leukemia Therapeutics Market Drivers
2.3.3 Hairy Cell Leukemia Therapeutics Market Challenges
2.3.4 Hairy Cell Leukemia Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hairy Cell Leukemia Therapeutics Players by Revenue
3.1.1 Global Top Hairy Cell Leukemia Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Hairy Cell Leukemia Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Hairy Cell Leukemia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hairy Cell Leukemia Therapeutics Revenue
3.4 Global Hairy Cell Leukemia Therapeutics Market Concentration Ratio
3.4.1 Global Hairy Cell Leukemia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hairy Cell Leukemia Therapeutics Revenue in 2020
3.5 Hairy Cell Leukemia Therapeutics Key Players Head office and Area Served
3.6 Key Players Hairy Cell Leukemia Therapeutics Product Solution and Service
3.7 Date of Enter into Hairy Cell Leukemia Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hairy Cell Leukemia Therapeutics Breakdown Data by Type
4.1 Global Hairy Cell Leukemia Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Hairy Cell Leukemia Therapeutics Forecasted Market Size by Type (2022-2027)

5 Hairy Cell Leukemia Therapeutics Breakdown Data by Application
5.1 Global Hairy Cell Leukemia Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Hairy Cell Leukemia Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hairy Cell Leukemia Therapeutics Market Size (2016-2027)
6.2 North America Hairy Cell Leukemia Therapeutics Market Size by Type
6.2.1 North America Hairy Cell Leukemia Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Hairy Cell Leukemia Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Hairy Cell Leukemia Therapeutics Market Size by Type (2016-2027)
6.3 North America Hairy Cell Leukemia Therapeutics Market Size by Application
6.3.1 North America Hairy Cell Leukemia Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Hairy Cell Leukemia Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Hairy Cell Leukemia Therapeutics Market Size by Application (2016-2027)
6.4 North America Hairy Cell Leukemia Therapeutics Market Size by Country
6.4.1 North America Hairy Cell Leukemia Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Hairy Cell Leukemia Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Hairy Cell Leukemia Therapeutics Market Size (2016-2027)
7.2 Europe Hairy Cell Leukemia Therapeutics Market Size by Type
7.2.1 Europe Hairy Cell Leukemia Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Hairy Cell Leukemia Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Hairy Cell Leukemia Therapeutics Market Size by Type (2016-2027)
7.3 Europe Hairy Cell Leukemia Therapeutics Market Size by Application
7.3.1 Europe Hairy Cell Leukemia Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Hairy Cell Leukemia Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Hairy Cell Leukemia Therapeutics Market Size by Application (2016-2027)
7.4 Europe Hairy Cell Leukemia Therapeutics Market Size by Country
7.4.1 Europe Hairy Cell Leukemia Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Hairy Cell Leukemia Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hairy Cell Leukemia Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Hairy Cell Leukemia Therapeutics Market Size by Type
8.2.1 Asia-Pacific Hairy Cell Leukemia Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hairy Cell Leukemia Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hairy Cell Leukemia Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Hairy Cell Leukemia Therapeutics Market Size by Application
8.3.1 Asia-Pacific Hairy Cell Leukemia Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hairy Cell Leukemia Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hairy Cell Leukemia Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Hairy Cell Leukemia Therapeutics Market Size by Region
8.4.1 Asia-Pacific Hairy Cell Leukemia Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hairy Cell Leukemia Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hairy Cell Leukemia Therapeutics Market Size (2016-2027)
9.2 Latin America Hairy Cell Leukemia Therapeutics Market Size by Type
9.2.1 Latin America Hairy Cell Leukemia Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Hairy Cell Leukemia Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Hairy Cell Leukemia Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Hairy Cell Leukemia Therapeutics Market Size by Application
9.3.1 Latin America Hairy Cell Leukemia Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Hairy Cell Leukemia Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Hairy Cell Leukemia Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Hairy Cell Leukemia Therapeutics Market Size by Country
9.4.1 Latin America Hairy Cell Leukemia Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Hairy Cell Leukemia Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hairy Cell Leukemia Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Hairy Cell Leukemia Therapeutics Market Size by Type
10.2.1 Middle East & Africa Hairy Cell Leukemia Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hairy Cell Leukemia Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hairy Cell Leukemia Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Hairy Cell Leukemia Therapeutics Market Size by Application
10.3.1 Middle East & Africa Hairy Cell Leukemia Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hairy Cell Leukemia Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hairy Cell Leukemia Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Hairy Cell Leukemia Therapeutics Market Size by Country
10.4.1 Middle East & Africa Hairy Cell Leukemia Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hairy Cell Leukemia Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie Inc
11.1.1 AbbVie Inc Company Details
11.1.2 AbbVie Inc Business Overview
11.1.3 AbbVie Inc Hairy Cell Leukemia Therapeutics Introduction
11.1.4 AbbVie Inc Revenue in Hairy Cell Leukemia Therapeutics Business (2016-2021)
11.1.5 AbbVie Inc Recent Development
11.2 ARA Healthcare Pvt Ltd
11.2.1 ARA Healthcare Pvt Ltd Company Details
11.2.2 ARA Healthcare Pvt Ltd Business Overview
11.2.3 ARA Healthcare Pvt Ltd Hairy Cell Leukemia Therapeutics Introduction
11.2.4 ARA Healthcare Pvt Ltd Revenue in Hairy Cell Leukemia Therapeutics Business (2016-2021)
11.2.5 ARA Healthcare Pvt Ltd Recent Development
11.3 Astellas Pharma Inc.
11.3.1 Astellas Pharma Inc. Company Details
11.3.2 Astellas Pharma Inc. Business Overview
11.3.3 Astellas Pharma Inc. Hairy Cell Leukemia Therapeutics Introduction
11.3.4 Astellas Pharma Inc. Revenue in Hairy Cell Leukemia Therapeutics Business (2016-2021)
11.3.5 Astellas Pharma Inc. Recent Development
11.4 Cellectis SA
11.4.1 Cellectis SA Company Details
11.4.2 Cellectis SA Business Overview
11.4.3 Cellectis SA Hairy Cell Leukemia Therapeutics Introduction
11.4.4 Cellectis SA Revenue in Hairy Cell Leukemia Therapeutics Business (2016-2021)
11.4.5 Cellectis SA Recent Development
11.5 F. Hoffmann-La Roche Ltd
11.5.1 F. Hoffmann-La Roche Ltd Company Details
11.5.2 F. Hoffmann-La Roche Ltd Business Overview
11.5.3 F. Hoffmann-La Roche Ltd Hairy Cell Leukemia Therapeutics Introduction
11.5.4 F. Hoffmann-La Roche Ltd Revenue in Hairy Cell Leukemia Therapeutics Business (2016-2021)
11.5.5 F. Hoffmann-La Roche Ltd Recent Development
11.6 Incyte Corp
11.6.1 Incyte Corp Company Details
11.6.2 Incyte Corp Business Overview
11.6.3 Incyte Corp Hairy Cell Leukemia Therapeutics Introduction
11.6.4 Incyte Corp Revenue in Hairy Cell Leukemia Therapeutics Business (2016-2021)
11.6.5 Incyte Corp Recent Development
11.7 Juno Therapeutics Inc
11.7.1 Juno Therapeutics Inc Company Details
11.7.2 Juno Therapeutics Inc Business Overview
11.7.3 Juno Therapeutics Inc Hairy Cell Leukemia Therapeutics Introduction
11.7.4 Juno Therapeutics Inc Revenue in Hairy Cell Leukemia Therapeutics Business (2016-2021)
11.7.5 Juno Therapeutics Inc Recent Development
11.8 MedImmune LLC
11.8.1 MedImmune LLC Company Details
11.8.2 MedImmune LLC Business Overview
11.8.3 MedImmune LLC Hairy Cell Leukemia Therapeutics Introduction
11.8.4 MedImmune LLC Revenue in Hairy Cell Leukemia Therapeutics Business (2016-2021)
11.8.5 MedImmune LLC Recent Development
11.9 Novartis AG
11.9.1 Novartis AG Company Details
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Hairy Cell Leukemia Therapeutics Introduction
11.9.4 Novartis AG Revenue in Hairy Cell Leukemia Therapeutics Business (2016-2021)
11.9.5 Novartis AG Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hairy Cell Leukemia Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Dezapelisib
Table 3. Key Players of ELB-021
Table 4. Key Players of Ibrutinib
Table 5. Key Players of AGS-67E
Table 6. Key Players of ARABS-4
Table 7. Key Players of Others
Table 8. Global Hairy Cell Leukemia Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Hairy Cell Leukemia Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Hairy Cell Leukemia Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Hairy Cell Leukemia Therapeutics Market Share by Regions (2016-2021)
Table 12. Global Hairy Cell Leukemia Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Hairy Cell Leukemia Therapeutics Market Share by Regions (2022-2027)
Table 14. Hairy Cell Leukemia Therapeutics Market Trends
Table 15. Hairy Cell Leukemia Therapeutics Market Drivers
Table 16. Hairy Cell Leukemia Therapeutics Market Challenges
Table 17. Hairy Cell Leukemia Therapeutics Market Restraints
Table 18. Global Hairy Cell Leukemia Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Hairy Cell Leukemia Therapeutics Market Share by Players (2016-2021)
Table 20. Global Top Hairy Cell Leukemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hairy Cell Leukemia Therapeutics as of 2020)
Table 21. Ranking of Global Top Hairy Cell Leukemia Therapeutics Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Hairy Cell Leukemia Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Hairy Cell Leukemia Therapeutics Product Solution and Service
Table 25. Date of Enter into Hairy Cell Leukemia Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Hairy Cell Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Hairy Cell Leukemia Therapeutics Revenue Market Share by Type (2016-2021)
Table 29. Global Hairy Cell Leukemia Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Hairy Cell Leukemia Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Hairy Cell Leukemia Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Hairy Cell Leukemia Therapeutics Revenue Market Share by Application (2016-2021)
Table 33. Global Hairy Cell Leukemia Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Hairy Cell Leukemia Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Hairy Cell Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Hairy Cell Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Hairy Cell Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Hairy Cell Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Hairy Cell Leukemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Hairy Cell Leukemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Hairy Cell Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Hairy Cell Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Hairy Cell Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Hairy Cell Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Hairy Cell Leukemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Hairy Cell Leukemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hairy Cell Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Hairy Cell Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Hairy Cell Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Hairy Cell Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Hairy Cell Leukemia Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Hairy Cell Leukemia Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Hairy Cell Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Hairy Cell Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Hairy Cell Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Hairy Cell Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Hairy Cell Leukemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Hairy Cell Leukemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hairy Cell Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Hairy Cell Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Hairy Cell Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Hairy Cell Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Hairy Cell Leukemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Hairy Cell Leukemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 65. AbbVie Inc Company Details
Table 66. AbbVie Inc Business Overview
Table 67. AbbVie Inc Hairy Cell Leukemia Therapeutics Product
Table 68. AbbVie Inc Revenue in Hairy Cell Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 69. AbbVie Inc Recent Development
Table 70. ARA Healthcare Pvt Ltd Company Details
Table 71. ARA Healthcare Pvt Ltd Business Overview
Table 72. ARA Healthcare Pvt Ltd Hairy Cell Leukemia Therapeutics Product
Table 73. ARA Healthcare Pvt Ltd Revenue in Hairy Cell Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 74. ARA Healthcare Pvt Ltd Recent Development
Table 75. Astellas Pharma Inc. Company Details
Table 76. Astellas Pharma Inc. Business Overview
Table 77. Astellas Pharma Inc. Hairy Cell Leukemia Therapeutics Product
Table 78. Astellas Pharma Inc. Revenue in Hairy Cell Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 79. Astellas Pharma Inc. Recent Development
Table 80. Cellectis SA Company Details
Table 81. Cellectis SA Business Overview
Table 82. Cellectis SA Hairy Cell Leukemia Therapeutics Product
Table 83. Cellectis SA Revenue in Hairy Cell Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 84. Cellectis SA Recent Development
Table 85. F. Hoffmann-La Roche Ltd Company Details
Table 86. F. Hoffmann-La Roche Ltd Business Overview
Table 87. F. Hoffmann-La Roche Ltd Hairy Cell Leukemia Therapeutics Product
Table 88. F. Hoffmann-La Roche Ltd Revenue in Hairy Cell Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 89. F. Hoffmann-La Roche Ltd Recent Development
Table 90. Incyte Corp Company Details
Table 91. Incyte Corp Business Overview
Table 92. Incyte Corp Hairy Cell Leukemia Therapeutics Product
Table 93. Incyte Corp Revenue in Hairy Cell Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 94. Incyte Corp Recent Development
Table 95. Juno Therapeutics Inc Company Details
Table 96. Juno Therapeutics Inc Business Overview
Table 97. Juno Therapeutics Inc Hairy Cell Leukemia Therapeutics Product
Table 98. Juno Therapeutics Inc Revenue in Hairy Cell Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Juno Therapeutics Inc Recent Development
Table 100. MedImmune LLC Company Details
Table 101. MedImmune LLC Business Overview
Table 102. MedImmune LLC Revenue in Hairy Cell Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 103. MedImmune LLC Recent Development
Table 104. Novartis AG Company Details
Table 105. Novartis AG Business Overview
Table 106. Novartis AG Hairy Cell Leukemia Therapeutics Product
Table 107. Novartis AG Revenue in Hairy Cell Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 108. Novartis AG Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hairy Cell Leukemia Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Dezapelisib Features
Figure 3. ELB-021 Features
Figure 4. Ibrutinib Features
Figure 5. AGS-67E Features
Figure 6. ARABS-4 Features
Figure 7. Others Features
Figure 8. Global Hairy Cell Leukemia Therapeutics Market Share by Application: 2020 VS 2027
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Hairy Cell Leukemia Therapeutics Report Years Considered
Figure 13. Global Hairy Cell Leukemia Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Hairy Cell Leukemia Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Hairy Cell Leukemia Therapeutics Market Share by Regions: 2020 VS 2027
Figure 16. Global Hairy Cell Leukemia Therapeutics Market Share by Regions (2022-2027)
Figure 17. Global Hairy Cell Leukemia Therapeutics Market Share by Players in 2020
Figure 18. Global Top Hairy Cell Leukemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hairy Cell Leukemia Therapeutics as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Hairy Cell Leukemia Therapeutics Revenue in 2020
Figure 20. Global Hairy Cell Leukemia Therapeutics Revenue Market Share by Type (2016-2021)
Figure 21. Global Hairy Cell Leukemia Therapeutics Revenue Market Share by Type (2022-2027)
Figure 22. North America Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Hairy Cell Leukemia Therapeutics Market Share by Type (2016-2027)
Figure 24. North America Hairy Cell Leukemia Therapeutics Market Share by Application (2016-2027)
Figure 25. North America Hairy Cell Leukemia Therapeutics Market Share by Country (2016-2027)
Figure 26. United States Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Hairy Cell Leukemia Therapeutics Market Share by Type (2016-2027)
Figure 30. Europe Hairy Cell Leukemia Therapeutics Market Share by Application (2016-2027)
Figure 31. Europe Hairy Cell Leukemia Therapeutics Market Share by Country (2016-2027)
Figure 32. Germany Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Hairy Cell Leukemia Therapeutics Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Hairy Cell Leukemia Therapeutics Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Hairy Cell Leukemia Therapeutics Market Share by Region (2016-2027)
Figure 42. China Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Hairy Cell Leukemia Therapeutics Market Share by Type (2016-2027)
Figure 50. Latin America Hairy Cell Leukemia Therapeutics Market Share by Application (2016-2027)
Figure 51. Latin America Hairy Cell Leukemia Therapeutics Market Share by Country (2016-2027)
Figure 52. Mexico Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Hairy Cell Leukemia Therapeutics Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Hairy Cell Leukemia Therapeutics Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Hairy Cell Leukemia Therapeutics Market Share by Country (2016-2027)
Figure 58. Turkey Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. AbbVie Inc Revenue Growth Rate in Hairy Cell Leukemia Therapeutics Business (2016-2021)
Figure 62. ARA Healthcare Pvt Ltd Revenue Growth Rate in Hairy Cell Leukemia Therapeutics Business (2016-2021)
Figure 63. Astellas Pharma Inc. Revenue Growth Rate in Hairy Cell Leukemia Therapeutics Business (2016-2021)
Figure 64. Cellectis SA Revenue Growth Rate in Hairy Cell Leukemia Therapeutics Business (2016-2021)
Figure 65. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Hairy Cell Leukemia Therapeutics Business (2016-2021)
Figure 66. Incyte Corp Revenue Growth Rate in Hairy Cell Leukemia Therapeutics Business (2016-2021)
Figure 67. Juno Therapeutics Inc Revenue Growth Rate in Hairy Cell Leukemia Therapeutics Business (2016-2021)
Figure 68. MedImmune LLC Revenue Growth Rate in Hairy Cell Leukemia Therapeutics Business (2016-2021)
Figure 69. Novartis AG Revenue Growth Rate in Hairy Cell Leukemia Therapeutics Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---